PATH-08. THE PROGNOSTIC VALUE OF A NOVEL QUANTITATIVE MGMT PROMOTER METHYLATION SCORE FOR PATIENTS WITH GLIOBLASTOMA

BACKGROUND: Methylation status of the O 6-methylguanine–DNA methyltransferase (MGMT) gene promoter is a well-known prognostic marker in glioblastoma, with prior studies demonstrating that methylated MGMT promoter corresponds to increased overall survival (OS) and progression free survival (PFS). MGM...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Neuro Oncol
Autori principali: Ravi, Akshay, Molinaro, Annette, Han, Seunggu J, Chehab, Farid, Berger, Mitchel S, Butowski, Nicholas
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2017
Soggetti:
Abstracts
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5692076/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.699
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi